In addition, some specific features of CDNF, including its selectivity for DAergic neurons, having low side-effects and higher effectiveness at low or medium concentration than GDNF and BDNF making it a promising candidate for PD treatment (Nasrolahi et al., 2018[25]; Tang et al., 2017[38]). The gene discussed is GDNF; the disease is Parkinson disease.